Cargando…

Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study

BACKGROUND: Host determinants of severe coronavirus disease 2019 include advanced age, comorbidities and male sex. Virologic factors may also be important in determining clinical outcome and transmission rates, but limited patient-level data is available. METHODS: We conducted an observational cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Barnaby E, Wei, Wycliffe E, Fong, Siew-Wai, Mak, Tze-Minn, Anderson, Danielle E, Chan, Yi-Hao, Pung, Rachael, Heng, Cheryl SY, Ang, Li Wei, Zheng, Adrian Kang Eng, Lee, Bernett, Kalimuddin, Shirin, Pada, Surinder, Tambyah, Paul A, Parthasarathy, Purnima, Tan, Seow Yen, Sun, Louisa, Smith, Gavin JD, Lin, Raymond Tzer Pin, Leo, Yee-Sin, Renia, Laurent, Wang, Lin-Fa, Ng, Lisa FP, Maurer-Stroh, Sebastian, Lye, David Chien, Lee, Vernon J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027908/
https://www.ncbi.nlm.nih.gov/pubmed/33840632
http://dx.doi.org/10.1016/j.ebiom.2021.103319
_version_ 1783675888220504064
author Young, Barnaby E
Wei, Wycliffe E
Fong, Siew-Wai
Mak, Tze-Minn
Anderson, Danielle E
Chan, Yi-Hao
Pung, Rachael
Heng, Cheryl SY
Ang, Li Wei
Zheng, Adrian Kang Eng
Lee, Bernett
Kalimuddin, Shirin
Pada, Surinder
Tambyah, Paul A
Parthasarathy, Purnima
Tan, Seow Yen
Sun, Louisa
Smith, Gavin JD
Lin, Raymond Tzer Pin
Leo, Yee-Sin
Renia, Laurent
Wang, Lin-Fa
Ng, Lisa FP
Maurer-Stroh, Sebastian
Lye, David Chien
Lee, Vernon J
author_facet Young, Barnaby E
Wei, Wycliffe E
Fong, Siew-Wai
Mak, Tze-Minn
Anderson, Danielle E
Chan, Yi-Hao
Pung, Rachael
Heng, Cheryl SY
Ang, Li Wei
Zheng, Adrian Kang Eng
Lee, Bernett
Kalimuddin, Shirin
Pada, Surinder
Tambyah, Paul A
Parthasarathy, Purnima
Tan, Seow Yen
Sun, Louisa
Smith, Gavin JD
Lin, Raymond Tzer Pin
Leo, Yee-Sin
Renia, Laurent
Wang, Lin-Fa
Ng, Lisa FP
Maurer-Stroh, Sebastian
Lye, David Chien
Lee, Vernon J
author_sort Young, Barnaby E
collection PubMed
description BACKGROUND: Host determinants of severe coronavirus disease 2019 include advanced age, comorbidities and male sex. Virologic factors may also be important in determining clinical outcome and transmission rates, but limited patient-level data is available. METHODS: We conducted an observational cohort study at seven public hospitals in Singapore. Clinical and laboratory data were collected and compared between individuals infected with different SARS-CoV-2 clades. Firth's logistic regression was used to examine the association between SARS-CoV-2 clade and development of hypoxia, and quasi-Poisson regression to compare transmission rates. Plasma samples were tested for immune mediator levels and the kinetics of viral replication in cell culture were compared. FINDINGS: 319 patients with PCR-confirmed SARS-CoV-2 infection had clinical and virologic data available for analysis. 29 (9%) were infected with clade S, 90 (28%) with clade L/V, 96 (30%) with clade G (containing D614G variant), and 104 (33%) with other clades ‘O’ were assigned to lineage B.6. After adjusting for age and other covariates, infections with clade S (adjusted odds ratio (aOR) 0·030 (95% confidence intervals (CI): 0·0002–0·29)) or clade O (B·6) (aOR 0·26 (95% CI 0·064–0·93)) were associated with lower odds of developing hypoxia requiring supplemental oxygen compared with clade L/V. Patients infected with clade L/V had more pronounced systemic inflammation with higher concentrations of pro-inflammatory cytokines, chemokines and growth factors. No significant difference in the severity of clade G infections was observed (aOR 0·95 (95% CI: 0·35–2·52). Though viral loads were significantly higher, there was no evidence of increased transmissibility of clade G, and replicative fitness in cell culture was similar for all clades. INTERPRETATION: Infection with clades L/V was associated with increased severity and more systemic release of pro-inflammatory cytokines. Infection with clade G was not associated with changes in severity, and despite higher viral loads there was no evidence of increased transmissibility.
format Online
Article
Text
id pubmed-8027908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-80279082021-04-08 Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study Young, Barnaby E Wei, Wycliffe E Fong, Siew-Wai Mak, Tze-Minn Anderson, Danielle E Chan, Yi-Hao Pung, Rachael Heng, Cheryl SY Ang, Li Wei Zheng, Adrian Kang Eng Lee, Bernett Kalimuddin, Shirin Pada, Surinder Tambyah, Paul A Parthasarathy, Purnima Tan, Seow Yen Sun, Louisa Smith, Gavin JD Lin, Raymond Tzer Pin Leo, Yee-Sin Renia, Laurent Wang, Lin-Fa Ng, Lisa FP Maurer-Stroh, Sebastian Lye, David Chien Lee, Vernon J EBioMedicine Research Paper BACKGROUND: Host determinants of severe coronavirus disease 2019 include advanced age, comorbidities and male sex. Virologic factors may also be important in determining clinical outcome and transmission rates, but limited patient-level data is available. METHODS: We conducted an observational cohort study at seven public hospitals in Singapore. Clinical and laboratory data were collected and compared between individuals infected with different SARS-CoV-2 clades. Firth's logistic regression was used to examine the association between SARS-CoV-2 clade and development of hypoxia, and quasi-Poisson regression to compare transmission rates. Plasma samples were tested for immune mediator levels and the kinetics of viral replication in cell culture were compared. FINDINGS: 319 patients with PCR-confirmed SARS-CoV-2 infection had clinical and virologic data available for analysis. 29 (9%) were infected with clade S, 90 (28%) with clade L/V, 96 (30%) with clade G (containing D614G variant), and 104 (33%) with other clades ‘O’ were assigned to lineage B.6. After adjusting for age and other covariates, infections with clade S (adjusted odds ratio (aOR) 0·030 (95% confidence intervals (CI): 0·0002–0·29)) or clade O (B·6) (aOR 0·26 (95% CI 0·064–0·93)) were associated with lower odds of developing hypoxia requiring supplemental oxygen compared with clade L/V. Patients infected with clade L/V had more pronounced systemic inflammation with higher concentrations of pro-inflammatory cytokines, chemokines and growth factors. No significant difference in the severity of clade G infections was observed (aOR 0·95 (95% CI: 0·35–2·52). Though viral loads were significantly higher, there was no evidence of increased transmissibility of clade G, and replicative fitness in cell culture was similar for all clades. INTERPRETATION: Infection with clades L/V was associated with increased severity and more systemic release of pro-inflammatory cytokines. Infection with clade G was not associated with changes in severity, and despite higher viral loads there was no evidence of increased transmissibility. Elsevier 2021-04-08 /pmc/articles/PMC8027908/ /pubmed/33840632 http://dx.doi.org/10.1016/j.ebiom.2021.103319 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Young, Barnaby E
Wei, Wycliffe E
Fong, Siew-Wai
Mak, Tze-Minn
Anderson, Danielle E
Chan, Yi-Hao
Pung, Rachael
Heng, Cheryl SY
Ang, Li Wei
Zheng, Adrian Kang Eng
Lee, Bernett
Kalimuddin, Shirin
Pada, Surinder
Tambyah, Paul A
Parthasarathy, Purnima
Tan, Seow Yen
Sun, Louisa
Smith, Gavin JD
Lin, Raymond Tzer Pin
Leo, Yee-Sin
Renia, Laurent
Wang, Lin-Fa
Ng, Lisa FP
Maurer-Stroh, Sebastian
Lye, David Chien
Lee, Vernon J
Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
title Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
title_full Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
title_fullStr Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
title_full_unstemmed Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
title_short Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study
title_sort association of sars-cov-2 clades with clinical, inflammatory and virologic outcomes: an observational study
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027908/
https://www.ncbi.nlm.nih.gov/pubmed/33840632
http://dx.doi.org/10.1016/j.ebiom.2021.103319
work_keys_str_mv AT youngbarnabye associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT weiwycliffee associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT fongsiewwai associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT maktzeminn associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT andersondaniellee associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT chanyihao associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT pungrachael associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT hengcherylsy associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT angliwei associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT zhengadriankangeng associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT leebernett associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT kalimuddinshirin associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT padasurinder associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT tambyahpaula associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT parthasarathypurnima associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT tanseowyen associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT sunlouisa associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT smithgavinjd associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT linraymondtzerpin associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT leoyeesin associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT renialaurent associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT wanglinfa associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT nglisafp associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT maurerstrohsebastian associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT lyedavidchien associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy
AT leevernonj associationofsarscov2cladeswithclinicalinflammatoryandvirologicoutcomesanobservationalstudy